Table 1.
Sample | Passage | CD29 | CD44 | CD105 | CD106 | Sca-1 | c-kit | CD11b | CD45 |
---|---|---|---|---|---|---|---|---|---|
AT-MSC | P3 | 99.8 ± 0.1 | 18.3 ± 1.3 | 50.1 ± 2.4 | 38.1 ± 3.2 | 98.5 ± 0.7 | 2.1 ± 0.6 | 0.99 ± 0.2 | 0.71 ± 0.2 |
P7 | 99.9 ± 0.0 | 41.8 ± 3.4 * | 33.6 ± 4.3 * | 54.3 ± 3.6 * | 26.3 ± 4.4 ** | 1.8 ± 1.0 | 0.11 ± 0.1 * | 0.1 ± 0.0 * | |
CB-MSC | P3 | 89.6 ± 4.2 | 87.9 ± 2.6 | 34.2 ± 3.3 | 60.2 ± 4.1 | 83.9 ± 5.4 | 6.7 ± 1.3 | 0.84 ± 0.4 | 38.4 ± 3.6 |
P7 | 99.9 ± 0.1 | 94.5 ± 2.7 | 7.5 ± 1.7 * | 99.1 ± 0.5 ** | 97.0 ± 1.8 * | 0.3 ± 0.2 * | 0.51 ± 0.3 | 1.1 ± 0.3 * |
* p < 0.05 and ** p < 0.01 in the comparison between P3 and P7.